Journal article · 2024 · Open access

Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease

Lydia Finney, Peter S Fenwick, Samuel V. Kemp, Aran Singanayagam, Michael R. Edwards, Kylie B. R. Belchamber, Tatiana Kebadze, Eteri Regis, Gavin C. Donaldson, Patrick Mallia, Louise Donnelly, Sebastian Lennox Johnston and 1 more

American Journal of Physiology-Lung Cellular and Molecular Physiology, 328(1), L120–L133 · Published 19 November 2024 · DOI 10.1152/ajplung.00118.2024

Open full textCite this paper

In brief

“Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease” is a 2024 journal article by Lydia Finney and 12 co-authors, published in American Journal of Physiology-Lung Cellular and Molecular Physiology. OpenAlex counts 9 citations as of 21 November 2026, which puts it in the top 5% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at American Journal of Physiology-Lung Cellular and Molecular Physiology.

Citations
9
Most cited in
2026 (6)
Field-weighted impact
2.07
References
45
Authors
13

Abstract

COPD exacerbations are commonly triggered by viral infections. Some patients with COPD have frequent exacerbations leading to rapid lung function decline and increased mortality. In this study, antiviral responses (interferons) from bronchial epithelial cells and alveolar macrophages were reduced in patients with COPD compared with healthy participants and further reduced in patients with COPD with frequent exacerbations. Impaired antiviral immunity may lead to frequent COPD exacerbations. Targeted vaccinations and antiviral therapy may reduce exacerbations in COPD.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Finney, L., Fenwick, P. S., Kemp, S. V., Singanayagam, A., Edwards, M. R., Belchamber, K. B. R., Kebadze, T., Regis, E., Donaldson, G. C., Mallia, P., Donnelly, L., Johnston, S. L., & Wedzicha, J. A. (2024). Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease. American Journal of Physiology-Lung Cellular and Molecular Physiology, 328(1), L120–L133. https://doi.org/10.1152/ajplung.00118.2024

MLA 9

Finney, Lydia, et al. “Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease.” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 328, no. 1, 2024, pp. L120–L133. https://doi.org/10.1152/ajplung.00118.2024.

Chicago

Finney, Lydia, Peter S Fenwick, Samuel V. Kemp, Aran Singanayagam, Michael R. Edwards, Kylie B. R. Belchamber, Tatiana Kebadze, et al. 2024. “Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease.” American Journal of Physiology-Lung Cellular and Molecular Physiology 328 (1): L120–L133. https://doi.org/10.1152/ajplung.00118.2024.

Harvard

Finney, L. et al. (2024) ‘Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease’, American Journal of Physiology-Lung Cellular and Molecular Physiology, 328(1), pp. L120–L133. doi:10.1152/ajplung.00118.2024.

IEEE

L. Finney et al., “Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 328, no. 1, pp. L120–L133, 2024, doi: 10.1152/ajplung.00118.2024.

BibTeX

@article{finney2024impaired,
  title     = {{Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease}},
  author    = {Finney, Lydia and Fenwick, Peter S and Kemp, Samuel V. and Singanayagam, Aran and Edwards, Michael R. and Belchamber, Kylie B. R. and Kebadze, Tatiana and Regis, Eteri and Donaldson, Gavin C. and Mallia, Patrick and Donnelly, Louise and Johnston, Sebastian Lennox and Wedzicha, Jadwiga Anna},
  journal   = {American Journal of Physiology-Lung Cellular and Molecular Physiology},
  year      = {2024},
  volume    = {328},
  number    = {1},
  pages     = {L120--L133},
  doi       = {10.1152/ajplung.00118.2024},
  url       = {https://doi.org/10.1152/ajplung.00118.2024}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research

  • chronic obstructive pulmonary disease
  • COPD exacerbations
  • antiviral immunity
  • interferon
  • bronchial epithelial cells
  • alveolar macrophages
  • viral infection
  • lung function decline

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Finney, L., Fenwick, P. S., Kemp, S. V., Singanayagam, A., Edwards, M. R., Belchamber, K. B. R., Kebadze, T., Regis, E., Donaldson, G. C., Mallia, P., Donnelly, L., Johnston, S. L., & Wedzicha, J. A. (2024). Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease. American Journal of Physiology-Lung Cellular and Molecular Physiology, 328(1), L120–L133. https://doi.org/10.1152/ajplung.00118.2024

How many times has this paper been cited?

9 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at American Journal of Physiology-Lung Cellular and Molecular Physiology: sign in and open the full text from this page.

Who wrote this paper?

Lydia Finney, Peter S Fenwick, Samuel V. Kemp, Aran Singanayagam, Michael R. Edwards, Kylie B. R. Belchamber, Tatiana Kebadze, Eteri Regis, Gavin C. Donaldson, Patrick Mallia, Louise Donnelly, Sebastian Lennox Johnston and 1 more.

What is the DOI of this paper?

10.1152/ajplung.00118.2024, permanently at https://doi.org/10.1152/ajplung.00118.2024. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.